2018
DOI: 10.1080/14737159.2018.1498786
|View full text |Cite
|
Sign up to set email alerts
|

16S metagenomics for diagnosis of bloodstream infections: opportunities and pitfalls

Abstract: Bacterial bloodstream infections (BSI) form a large public health threat worldwide. Current routine diagnosis is based on blood culture (BC) but this technique suffers from limited sensitivity. Molecular diagnostic tools have been developed for identification of bacteria in the blood of BSI patients. 16S metagenomics is an open-ended technique that can detect simultaneously all bacteria in a given sample based on PCR amplification of the 16S ribosomal RNA gene (rDNA) followed by sequencing of the PCR amplicons… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
29
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
2
2

Relationship

1
7

Authors

Journals

citations
Cited by 32 publications
(30 citation statements)
references
References 71 publications
0
29
1
Order By: Relevance
“…On the other hand, 16S metagenomics can simultaneously detect all bacteria in a given blood sample based on PCR ampli cation of the 16S ribosomal RNA gene followed by deep sequencing of the PCR amplicons and taxonomic labelling of the sequence reads at genus or species level. However, the technique currently presents various technical limitations such as limited taxonomic resolution and high background signals jeopardizing its implementation in routine patients' diagnosis [11]. Based on the proof-of-concept presented here, 16S rRNA amplicon deep sequencing may be more sensitive than conventional 16S metagenomics at DNA level.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…On the other hand, 16S metagenomics can simultaneously detect all bacteria in a given blood sample based on PCR ampli cation of the 16S ribosomal RNA gene followed by deep sequencing of the PCR amplicons and taxonomic labelling of the sequence reads at genus or species level. However, the technique currently presents various technical limitations such as limited taxonomic resolution and high background signals jeopardizing its implementation in routine patients' diagnosis [11]. Based on the proof-of-concept presented here, 16S rRNA amplicon deep sequencing may be more sensitive than conventional 16S metagenomics at DNA level.…”
Section: Discussionmentioning
confidence: 98%
“…Current reference methods for Salmonella detection in blood rely on conventional blood culture followed by microbiological work-up for species and serotype identi cation. Microbiological methods are labour-intensive and generally take 6 to 48 hours before positive growth [11]. Various selective media for the identi cation of Salmonella have been developed and are commercially available.…”
Section: Introductionmentioning
confidence: 99%
“…were found (Hornok et al 2019). Identification of infectious bacteria from the bloodstream, particularly in humans are usually performed using blood cultures, but different studies compared this method with the 16S metagenomics, showing that this later technique is more sensitive and specific (Decuypere et al 2016, Rutanga et al 2018, Watanabe et al 2018]. The blood tested for those studies was fresh however there are no studies that have tested the sensitivity in partly degraded heart or heart tissue.…”
Section: Discussionmentioning
confidence: 99%
“…Another approach is 16S amplicon sequencing using PCR to amplify the common 16S ribosomal gene shared by all bacteria. DNA sequencing of this PCR product is then used to identify the specific bacteria ( 32 ). 16S amplicon techniques can, in theory, uncover bacterial pathogens in an unbiased manner.…”
Section: Limitations Of Emerging Technologies For Detecting Pathogensmentioning
confidence: 99%
“…However, contamination from clinical collection, laboratory reagents, or the laboratory environment can dominate the sequencing results if pathogen sequences in the patient sample are present in very low concentrations ( 31 ), which is often the case in NS. Bacterial DNA can be present in minute quantities and therefore difficult to detect within the much greater mass of contaminant bacterial DNA acquired during routine sequencing workflows ( 32 ).…”
Section: Limitations Of Emerging Technologies For Detecting Pathogensmentioning
confidence: 99%